Executive Panel: Scaling AI for Drug Design and Optimization

Oct 28, 2026
Discovery Chemistry

- Discuss how AI is reshaping the overall paradigm of molecular design and optimization in modern drug discovery.- Explore the challenges of scaling AI from promising tools to fully integrated discovery platforms across organizations.- Examine how collaboration between computational scientists, medicinal chemists and automation platforms is enabling truly scalable AI-driven chemistry.

Speakers
Peter Clark
Peter Clark, VP, Computational Drug Design - Novo Nordisk